u/halima_boateng
Contributes reviews on supplier material. Based in Brno.
member · joined 15 Jun 2025
Comments — page 4 of 5
comment on three years of certificate of analysis threads, summarised so you do not have to read them in c/coa · 15 points · 1 year ago
Batch number and date of analysis? Both are load-bearing.
comment on Germany: SURMOUNT, and what it actually costs here in c/tirzepatide · 1 points · 1 year ago
SURMOUNT data is messier than STEP data but the weight loss is there
comment on Germany: SURMOUNT, and what it actually costs here in c/tirzepatide · 414 points · 1 year ago
the 15mg is the top of the pen, not the required dose
comment on related substances is the most under-discussed thing in c/scamalerts in c/coa · 5 points · 1 year ago
PDF metadata is checkable in fifteen seconds
Adding to this: area percent is doing more work than the comment implies.
comment on [Question] Sweden — has anyone got a straight answer on MHRA in c/glp1uk · 115 points · 1 year ago
pharmacy stock is UK, check before traveling
comment on [Vendor] QST order #20 — Denmark, 39 days, no drama, receipts inside in c/tirzepatide · 101 points · 1 year ago
Did you stay on semaglutide or switch? The outcome is different if you are comparing.
comment on anyone else notice SURMOUNT kicking in around week 30 in c/tirzepatide · 291 points · 1 year ago
Week 42 on Mounjaro and 40kg down. The appetite reduction feels different from sema in ways I do not have words for yet.
comment on [Meta] the pricing rule is doing its job and people should stop complaining in c/glp1uk · 22 points · 1 year ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on anyone else notice SURMOUNT kicking in around week 80 in c/tirzepatide · 191 points · 1 year ago
week 81 on Mounjaro and the appetite profile is genuinely different from sema
comment on anyone else notice area percent kicking in around week 25 in c/coa · 66 points · 1 year ago
the related substances line is where the story is
comment on 24 months in and scam is still the thing I get wrong in c/scamalerts · 92 points · 1 year ago
the batch number appearing across three vendors is a red flag
comment on switched from 12.5mg to 0.5mg and the injection-site soreness got better, not worse in c/coa · 102 points · 1 year ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on three years of exit scam threads, summarised so you do not have to read them in c/scamalerts · 704 points · 2 years ago
comment on the tier 3 question that gets asked weekly, answered properly in c/glp1uk · 26 points · 2 years ago
no naming online pharmacies that prescribe without a consultation
comment on three years of exit scam threads, summarised so you do not have to read them in c/scamalerts · 577 points · 2 years ago
Not to be pedantic but exit scam and fake COA are being used interchangeably and they are not interchangeable in real life.
comment on batch — my 10-week log, condensed into one table in c/coa · 66 points · 2 years ago
Sent one vial to PeptideMeter and VendorInvestigate.
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
comment on [PSA] Mounjaro is not what most of this community thinks it is in c/tirzepatide · 288 points · 2 years ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Discussion] we are measuring COA at the wrong time and calling it noise in c/coa · 76 points · 2 years ago
Are you looking at area% or net peptide content? Different numbers.
comment on [Discussion] we are measuring COA at the wrong time and calling it noise in c/coa · 293 points · 2 years ago
the method line is doing real work, not just window dressing
comment on [Discussion] we are measuring COA at the wrong time and calling it noise in c/coa · 22 points · 2 years ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.